Author Archives: Jose Marques Lopes PhD

Orkambi, Symdeko and Kalydeco All of Benefit, But Too Costly to Be of Good Value to Patients, Midwest CEPAC Says

Vertex Pharmaceuticals’ treatments for cystic fibrosis (CF) all provide considerable benefits, but their pricing is not transparent and does not align with the medications clinical value, a review of the Institute for Clinical and Economic Review (ICER)’s report by the Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC)…